Advertisement

Topics

imaGenes GmbH Company Profile

08:31 EDT 3rd May 2016 | BioPortfolio

"imaGenes is a premier provider of genome research services in Europe and was founded in 2007 as a spin-off from RZPD (German Resource Center for Genome Research). imaGenes manages one of the most comprehensive collections of clones of mammalian and vertebrate genes in the world offered via its clone search engine GenomeCube, linked to international databases. The second major research services of imaGenes features microarray services on Affymetrix, Agilent, and NimbleGen platforms for a broad range of functional analyses. imaGenes is also offering next generation sequencing services on an Illumina Genome Analyzer System."

Location

Germany


News Articles [119 Associated News Articles listed on BioPortfolio]

Thermosome raises €4.6m

Thermosome GmbH, an emerging biopharmaceutical company, announced the closing of its first financing round, raising net proceeds of approximately €1.9 million from funds managed by High-Tech Gründe...

Marathon Patent Group Announces Update on TLI Communications GmbH Versus Yahoo! and MedTech Development Deutschland GmbH Versus Stryker GmbH & Co. KG

LOS ANGELES, CA -- (Marketwired) -- 10/29/15 -- Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"), a patent licensing company, announced a litigation update for TLI Communications GmbH ("TLI...

Original-Research: 4SC AG (von EQUITS GmbH): -

Original-Research: 4SC AG - von EQUITS GmbH Einstufung von EQUITS GmbH zu 4SC AG Unternehmen: 4SC AG ISIN: DE000A14KL72 Anlass der Studie: Peergroup Analyse, Initial Empfehlung: - Kursziel: - Kurs...

GUB Unternehmensbeteiligungen GmbH & Co. KGaA, VC Fonds Berlin GmbH, BioGenes deal

LUM GmbH starts exclusive distribution of PSI-homogenizers in several countries

With immediate effect LUM GmbH, Berlin, Germany, starts the exclusive distribution of PSI instruments in Germany, Austria, France and China. The distributorship agreement between the manufacturer Part...

BRIEF-Medistim enters into a strategic partnership with emtec GmbH

* Said on Thursday entered into a long-term agreement with em-tec GmbH

Nachgefragt: Thomas Helle über neue Entwicklungen im Bioleaching

Auf Vermittlung der BIOPRO Baden-Württemberg GmbH trat die Biotechnologiefirma Novis GmbH in Kontakt mit dem renommierten Geomikrobiologen Prof. Dr. Andreas Kappler. Die Partner testeten erste Biolea...

Repligen acquires Atoll

Repligen Corp acquired German chromatography column manufacturer Atoll GMBH from UV-Cap GMBH for $9.1mm in cash and 538.7k shares--a total of $22.5mm. Repligen could also pay a sales milestone of $1.1...

Drugs and Medications [0 Results]

None

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

A Biological Tissue Adhesive and Dissolvent System for Intraocular Tumor Plaque Brachytherapy.

To examine a novel technique for simplified placement and removal of plaque brachytherapy by fibrin glue and urokinase (medac Gmbh, Hamburg, Germany).

Preliminary Experience with a New Multidirectional Videoendoscope for Neuroendoscopic Surgical Procedures.

We assessed the applicability of a new multidirectional videoendoscope (digiCAMeleon, Karl Storz GmbH, Tuttlingen, Germany) in various neuroendoscopic procedures.

A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.

U.S. Food and Drug Administration-approved formulations of botulinum toxin include onabotulinumtoxinA (Botox; Allergan, Inc., Irvine, Calif.), abobotulinumtoxinA (Dysport; Galderma Pharma S.A., Lausan...

Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age.

This ongoing, prospective, open-label, non-comparative, multicenter phase IV study is evaluating the safety and efficacy of recombinant human growth hormone (rhGH; Omnitrope(®), Sandoz GmbH) in short...

Short-Term Clinical Experience with a Dedicated Venous Nitinol Stent: Initial Results with the Sinus-Venous.

Deep venous stenting has become the primary treatment option for chronic venous obstructive disease, both for iliac vein compression and post-thrombotic venous lesions. Until recently, only stents aim...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Telemedicine Monitoring of Sleep Apnea in Stroke

Study Objectives: Meta-analyses report a high prevalence of moderate to severe sleep apnea of more than 50% in stroke patients, with adherence rates for CPAP therapy of only 30%. T...

Companies [1 Associated Companies listed on BioPortfolio]

imaGenes GmbH

"imaGenes is a premier provider of genome research services in Europe and was founded in 2007 as a spin-off from RZPD (German Resource Center for Genome Research). imaGenes manages one of the most com...

More Information about "imaGenes GmbH" on BioPortfolio

We have published hundreds of imaGenes GmbH news stories on BioPortfolio along with dozens of imaGenes GmbH Clinical Trials and PubMed Articles about imaGenes GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of imaGenes GmbH Companies in our database. You can also find out about relevant imaGenes GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cloning
Cloning in biology is the process of producing similar populations of genetically identical individuals that occurs in nature when organisms such as bacteria, insects or plants reproduce asexually. Cloning in biotechnology refers to processes used to cre...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record